THAT THE FIRST APPLICATIONS OF THE CRISPR TECHNOLOGY ARE GOING TO HAPPEN IN THE BLOOD WHERE IT'S RELATIVELY EASIER TO DELIVER THIS TOOL INTO CELLS COMPARED TO SOLID TISSUES